The REDUCE-IT trial, published in the New England Journal of Medicine, was the gold standard. Over 8,000 patients with elevated triglycerides were given either 4g per day of icosapent ethyl (pure EPA in prescription form) or a placebo. The EPA group saw a 25% reduction in major cardiovascular events. In the highest-risk subgroup, it hit 35%.
That's a massive effect. Comparable to statins. But here's the asterisk: the supplement used was pharmaceutical-grade pure EPA at 4 grams per day. Not the 500mg fish oil capsule you bought at the supermarket. Not the gummy bears. Not the chia seed pudding.
Most over-the-counter fish oil provides 300mg of combined EPA+DHA per capsule. To get the dose used in REDUCE-IT, you'd need to swallow 13 of those capsules daily. Nobody does that. So the question becomes: can lower doses still help? And which form actually gets into your bloodstream?
Omega-3 is an umbrella term for three fatty acids, and they are wildly different in what they do.
EPA (eicosapentaenoic acid) is the anti-inflammatory powerhouse. It's the one with the strongest cardiovascular evidence. It reduces triglycerides, stabilises arterial plaque, and decreases inflammatory markers like C-reactive protein. This is the omega-3 your heart cares about.
DHA (docosahexaenoic acid) is the brain and eye fatty acid. It's a major structural component of neural membranes and retinal tissue. Critical for cognition, essential during pregnancy, but its direct cardiovascular benefit is less clear — some studies suggest high DHA may actually blunt EPA's triglyceride-lowering effect.
ALA (alpha-linolenic acid) is the plant omega-3 found in flaxseed, chia, and walnuts. Your body can convert ALA to EPA and DHA, but the conversion rate is pathetic — roughly 5-10% for EPA and under 5% for DHA. If you're relying on flaxseed oil for heart protection, you're bringing a water pistol to a house fire.
Most bargain fish oil is sold in ethyl ester form. It's cheaper to manufacture. But ethyl esters are absorbed 30-50% less efficiently than the triglyceride form that omega-3s naturally occur in.
So you're already taking a dose that's probably too low. And then you're absorbing half of it. You're getting maybe 150mg of usable EPA+DHA from that capsule. At that level, the cardiovascular benefit in clinical studies is essentially non-existent.
The forms that work: triglyceride-form fish oil (re-esterified triglycerides, or rTG), or phospholipid-form omega-3 from krill oil. Both have significantly higher bioavailability. You pay more per capsule, but you actually absorb what you're paying for.
The American Heart Association recommends 1g of combined EPA+DHA daily for people with documented heart disease. For triglyceride reduction, they recommend 2-4g under medical supervision. The European Society of Cardiology has similar guidelines.
For general cardiovascular prevention in healthy adults, most researchers now suggest a minimum of 1g EPA+DHA daily. That means a high-quality supplement delivering at least 500mg EPA and 500mg DHA per serving. Not per bottle. Per serving.
Read the label carefully. Many supplements list "1000mg fish oil" on the front, but when you flip to the back, only 300mg is actual EPA+DHA. The rest is other fats. That marketing trick is responsible for millions of people thinking they're getting adequate omega-3 when they're nowhere close.
Omega-3s work. The evidence is overwhelming. But the supplement industry has made it incredibly easy to take them wrong — wrong form, wrong dose, wrong expectations. If you're going to take fish oil, take it seriously: triglyceride form, 1g+ EPA+DHA daily, with food for absorption. Anything less is hope dressed up as healthcare.
Evidence-based health research, supplement guides & new articles — straight to your inbox.